Traduction de «elderly women efficacy and cost-effectiveness » (Néerlandais → Français) :

53. Zappa M, Visioli CB, Ciatto S. Mammography screening in elderly women: efficacy and cost-effectiveness.
52. Zappa M, Visioli CB, Ciatto S. Mammography screening in elderly women: efficacy and cost-effectiveness.

Six cost-benefit studies have concluded that these control policies are cost effective in situations where carriage rates on admission vary between 0.5 to 20 %, efficacy of control measures between 14 and 80 % and rate of infection among colonised patients is between 20 and 60 % 13, 14, 15, 16 .
Six études de coût-bénéfice ont conclu que ces politiques de contrôle sont rentables dans des situations où le taux de portage à l’admission varie entre 0,5 et 20 %, l’efficacité des mesures de contrôle entre 14 et 80 % et le taux d'infection chez les patients colonisés entre 20 et 60% 13, 14, 15, 16 .

Lederle F, Busch D, Mattox K et al. Cost-effective treatment in the elderly. A randomized double-blind comparison of sorbitol and lactulose.
A randomized double-blind comparison of sorbitol and lactulose.

48. Smith-Bindman R, Kerlikowske K, Gebretsadik T, Newman J. Is screening mammography effective in elderly women?
47. Smith-Bindman R, Kerlikowske K, Gebretsadik T, Newman J. Is screening mammography effective in elderly women?

Prince RL, Austin N, Devine A, Dick IM, Bruce D, Zhu K. Effects of ergocalciferol added to calcium on the of falls in elderly high-risk women.
Prince RL, Austin N, Devine A, Dick IM, Bruce D, Zhu K. Effects of ergocalciferol added to calcium on the risk of falls in elderly high-risk women.

56. Kerlikowske K, Salzmann P, Phillips KA, Cauley JA, Cummings SR. Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness.
55. Kerlikowske K, Salzmann P, Phillips KA, Cauley JA, Cummings SR. Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness.